<?xml version="1.0" encoding="UTF-8"?>
<ClinicalUseDefinition xmlns="http://hl7.org/fhir">
    <id value="CUD-Norway-1"/>
    <meta>
        <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-indication-uv-epi"/>
        <profile value="https://gravitatehealth.eu/fhir/nordic-epi-ig/StructureDefinition/Nordic-ePI-ClinicalUseDefinition-Indication"/>
    </meta>
    <type value="indication"/>
    <subject>
        <reference value="MedicinalProductDefinition/MPD-Norway-1"/>
    </subject>
    <indication>
        <diseaseSymptomProcedure>
            <concept>

                <!-- Example from the Vulcan ePI IG: -->
                <coding>
                    <system value="http://terminology.hl7.org/CodeSystem/mdr"/>
                    <code value="10037156"/>
                    <display value="Psoriasis"/>
                </coding>

                <!--
                Does the EMA PDF Implementation Guide define use of the original MedDRA ID, or the SPOR RMS ID?

                An example in the PDF is: 100000054740 Migraine headache
                In SPOR RMS List 100000000006 the term is:
                * Term Id: 100000054740 <- this is the ID in the example
                * Term Name: Migraine headache
                * Source Id: 10027602 <- this is in MedDRA as LLT (checked through the MedDRA WBB) 

                Should our example for Psoriasis be this?
                <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/100000000006/terms/"/>
                    <code value="100000018190"/>
                    <display value="Psoriasis"/>
                </coding>

                In this case, our CUD profile should also change the binding to a value set with SPOR codes.
                -->

            </concept>
        </diseaseSymptomProcedure>
    </indication>
</ClinicalUseDefinition>
